Home > Healthcare > Pharmaceuticals > Finished Drug Form > Methotrexate Drugs Market

Methotrexate Drugs Market Share

Report ID: GMI9756
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Methotrexate Drugs Market Share

The methotrexate drugs industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products and services based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.

Methotrexate Drugs Market Companies

Some of the eminent market participants operating in the methotrexate drugs industry include:

Accord Healthcare
Amneal Pharmaceuticals LLC
Apotex Inc.
Cipla Limited
Dr. Reddy’s Laboratories Ltd.
Hikma Pharmaceuticals PLC
Intas Pharmaceuticals Ltd.
Lupin Limited
Merck KGaA
Novartis AG
Pfizer Inc.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Zydus Cadila

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Global methotrexate drugs industry size was valued at USD 590.4 billion in 2023 and is estimated to grow at 3.1% CAGR from 2024 to 2032 due to increasing prevalence of cancer and the ongoing R&D using methotrexate drugs.

The cancer segment of the market is forecasted to reach USD 263.4 million by 2032 due to its effectiveness in treating various cancers, especially leukemia and metastatic breast cancer.

The hospital pharmacies segment of the methotrexate drugs market recorded USD 248.6 million in 2023 due to the need for provide specialized methotrexate formulations and follow robust safety protocols to enhance patient care and safety in clinical settings.

Accord Healthcare, Amneal Pharmaceuticals LLC, Apotex Inc., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Intas Pharmaceuticals Ltd., Lupin Limited, and Merck KGaA, among others.